Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Stent structure
Reexamination Certificate
2000-10-24
2003-07-22
Isabella, David J. (Department: 3731)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Stent structure
Reexamination Certificate
active
06596021
ABSTRACT:
The invention concerns a stent, in particular a coronary stent, comprising at least one first tubular portion and at least one second tubular portion, wherein the first and second tubular portions are connected together by at least one first connecting means.
Stents of that kind are known from the state of the art in many different forms. Those stents are used inter alia in connection with percutaneous transluminal angioplasty (PCTA, Percutaneous Transluminal Balloon Angioplasty), in vascular surgery of the heart. Stents however can also serve to dilate other openings in the body or to keep such openings in a dilated condition. That medical procedure is initially preceded by determining the location of the constriction in a coronary blood vessel. A so-called angioplasty balloon is then moved in the artery which has the constriction, the so-called stenosis, to the location of the stenosis where it is inflated. Due to the radially outwardly directed force of the inflated balloon the constriction is dilated and in the optimum case the original passage cross-section of the previously constricted artery is restored. Besides successful dilation of the vessel however side-effects can also occur, which include local splits in the artery, disintegration effects and projections of plate portions and flakes into the lumen of the artery so that, in spite of the dilation effect, blockage of the vessel can still occur. In addition it is possible that a stenosis can recur due to the vessel wall elastically springing back and/or due to the growth of the intima of the vessel. Statistically, that occurs within six months in the case of over 30% of the patients who were treated with PCTA.
In order now immediately after dilation of the blood vessel to ensure a relatively smooth inside wall surface for the vessel and to be able to avoid renewed stenosis, the stents set forth in the opening part of this specification were developed. Those small tubes serve inter alia in conjunction with PCTA to maintain the vessel flow cross-section which is produced by balloon angioplasty in order thereby to ensure long-term success with the PCTA procedure.
The success of such so-called stenting also depends inter alia on how uniformly the stent can come to bear against the wall of the vessel. For, the more uniformly the wall of the vessel is supported, the correspondingly more probable it is that vessel constrictions will not recur in the region of the stent. In that respect a regular stent structure produces a relatively smooth inside surface for the vessel and, with a relatively smooth inside vessel surface, blood particles can only be deposited thereon with difficulty. In addition growths of the intima into the interior of the vessel are prevented to a greater degree by a regular stent structure which covers over the inside surface of the vessel in a relatively closed configuration.
Stents of that kind with a so-called closed structure are also known from the state of the art. By way of example reference may be made here to one of the best-known stents of that kind, the so-called wall stent. That is known for example from U.S. Pat. No. 4,65,771. This stent which has a closed structure is formed from two wires which are regularly knitted in a mesh-like structure and which extend in a spiral configuration on the longitudinal axis of the stent.
The advantage of the closed structure of stents of that kind is however only achieved at the cost of the disadvantage that the stents involve relative longitudinal stiffness during insertion. Those stents do not therefore make it possible in the optimum manner for the stent to be guided through possibly very severely curved vessel portions in the coronary arteries upon insertion in a direction towards the stenosis to be treated. Those longitudinally stiff stents also cannot be used in the region of curvy vessel portions. In order to avoid those disadvantages of a closed structure, stents have now been developed which are of a so-called modular nature. In the case of those stents of a modular nature, individual portions which are provided with a closed structure are connected together by flexible connections. Stents of that kind are known for example from U.S. Pat. No. 5,104,404.
A disadvantage with the known modular or segmented stents however is that upon crimping of the stent (the term crimping is used to denote mounting the stent on the balloon catheter in a non-displaceable fashion by applying a gentle, radially inwardly directed pressure thereto), the stent may involve a non-uniform behavior. For, in the crimping operation the tubular portions exhibited a different behavior from the individual bars which serve as connecting means, between the tubular portions. In addition there is the disadvantage with the known stents for precisely those reasons that the stent also entails a non-uniform expansion characteristic. With that non-uniform expansion of the known stents the stent may involve inter alia a radial spreading movement of individual bars. That spreading movement is unwanted however as it interrupts the uniformity, which has already been referred to above, of the inside wall of the expanded stent. In addition that can also involve injury and damage to the intima of the stented vessel. In addition, in the case of conventional stents which are composed of various segments, expansion of the stent can involve the stent expanding in a shape referred to as a “dog-bone” shape. In that situation, the tubular portions which are at the ends of the stent are expanded to a greater degree than the tubular portions which are more in the central region of the stent. That is also disadvantageous for the above-discussed reasons, in particular in regard to durably suppressing further deposits on the inside wall of the stent.
Therefore the object of the present invention is to further develop a stent of the kind set forth in the opening part of this specification, in such a way that the above-mentioned disadvantages are avoided, and that there is made available a stent in which the flexural flexibility of segmented stents or stents which are also referred to as modular is maintained while at the same time the longitudinal stability of the stent is increased.
In a stent of the kind set forth in the opening part of this specification that object is attained in that the at least one first connecting means is in the form of a double bar.
By means of the double bar according to the invention the invention achieves a longitudinal stability for the stent which is markedly increased in comparison with conventional segmented stents while at the same time the flexural flexibility of the modular design of the stent is maintained. In that way by virtue of the invention it is possible for the stent not to be compressed during balloon dilation. In addition, because of the invention, the adjacent tubular portions cannot come into unwanted contact with each other. In that way, by means of the invention, adjacent tubular portions are prevented from influencing each other upon expansion of the stent in the balloon dilation procedure. In addition, the double bars according to the invention, in contrast to the single bars known from the state of the art, provide as a connecting means between the adjacent tubular portions for a more regular and uniform crimping and expansion behavior on the part of the stent. In that case the invention advantageously avoids inter alia radial spreading of bars upon balloon dilation and also prevents the tubular portions at the ends of the stents from expanding in a “dog-bone” configuration.
A particularly preferred embodiment of the invention is distinguished in that the tubular portions each comprise a plurality of cells, wherein the double bar according to the invention connects together cells, which are adjacent in the longitudinal direction of the stent, of the respective portions. This cell-type structure of the tubular portions provides for an optimum expansion behavior on the part of the stent upon expansion thereof.
In a further preferred embodiment the portions
Biotronik Mess -und Therapiegeraete GmbH & Co. Ingenieurbuero Be
Grant Stephen L.
Hahn Loeser & Parks LLP
Isabella David J.
Matthews William H.
LandOfFree
Stent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3032068